Electromedical Technologies annual cash and equivalents
2019
2020
2021
2022
2023
Electromedical Technologies Cash & Equivalents Growth & History (EMED)
Electromedical Technologies's cash and equivalents was $87,704 for fiscal 2023.
View full Electromedical Technologies company overviewElectromedical Technologies annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $87,704 | −$280,721 | −76.19% |
| 2022 | 2022-12-31 | $368,425 | −$14,745 | −3.85% |
| 2021 | 2021-12-31 | $383,170 | $118,257 | +44.64% |
| 2020 | 2020-12-31 | $264,913 | $264,913 | — |
| 2019 | 2019-12-31 | $0 | — | — |
Electromedical Technologies quarterly cash and equivalents
Q4.19
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $34,809 | −$103,668 | −74.86% |
| Q2 2024 | 2024-06-30 | $116,931 | −$299,325 | −71.91% |
| Q1 2024 | 2024-03-31 | $78,843 | −$1.2M | −93.62% |
| Q4 2023 | 2023-12-31 | $87,704 | −$280,721 | −76.19% |
| Q3 2023 | 2023-09-30 | $138,477 | −$320,438 | −69.83% |
| Q2 2023 | 2023-06-30 | $416,256 | $351,027 | +538.15% |
| Q1 2023 | 2023-03-31 | $1.2M | $1.1M | +626.28% |
| Q4 2022 | 2022-12-31 | $368,425 | −$14,745 | −3.85% |
| Q3 2022 | 2022-09-30 | $458,915 | $294,105 | +178.45% |
| Q2 2022 | 2022-06-30 | $65,229 | −$315,214 | −82.85% |
| Q1 2022 | 2022-03-31 | $170,048 | −$410,726 | −70.72% |
| Q4 2021 | 2021-12-31 | $383,170 | $118,257 | +44.64% |
| Q3 2021 | 2021-09-30 | $164,810 | $79,333 | +92.81% |
| Q2 2021 | 2021-06-30 | $380,443 | $253,367 | +199.38% |
| Q1 2021 | 2021-03-31 | $580,774 | — | — |
| Q4 2020 | 2020-12-31 | $264,913 | $264,913 | — |
| Q3 2020 | 2020-09-30 | $85,477 | — | — |
| Q2 2020 | 2020-06-30 | $127,076 | — | — |
| Q4 2019 | 2019-12-31 | $0 | — | — |
Electromedical Technologies cash and equivalents trends
Between the periods ended 2019-12-31 and 2023-12-31, Electromedical Technologies's cash and equivalents increased from $0 to $87,704, a change of $87,704. The latest reported quarter, Q3 2024, shows $34,809.
About the metric
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Calculation and source
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Electromedical Technologies source filings ↗